News
- Author:
- Neil Osterweil
Publish date: June 4, 2023
Vorasidenib was associated with a significant delay in time to disease progression when compared with placebo, in a new study.
News
- Author:
- Neil Osterweil
Publish date: June 4, 2023
Adding immunotherapy resulted in a 40% reduction in risk of death, compared with chemotherapy alone, for women with advanced cervical cancers expre...
News
- Author:
- Neil Osterweil
Publish date: June 4, 2023
New results come from an interim analysis of a phase 3 randomized trial comparing maintenance therapy with ribociclib plus endocrine therapy with a...
News
- Author:
- Neil Osterweil
Publish date: May 19, 2023
This would reduce potential harms from overdiagnosis and overtreatment, the risk for which is high with the on-demand screening that is the current...
News
- Author:
- Neil Osterweil
Publish date: May 17, 2023
Study presented at DDW finds that patient-derived sources are usually trustworthy, promotional sources are often misleading.
News
- Author:
- Neil Osterweil
Publish date: May 17, 2023
A new study suggests that with better diagnosis a significant proportion of patients with pancreatic cystic neoplasms could be spared from surgery....
News
- Author:
- Neil Osterweil
Publish date: May 17, 2023
Patients with ulcerative colitis and meat-heavy diets had twice as many flares as those who ate less meat.
News
- Author:
- Neil Osterweil
Publish date: May 9, 2023
Features of axial psoriatic arthritis and axial spondyloarthritis overlap, but whether they’re different diseases or on the same spectrum is unclea...
News
- Author:
- Neil Osterweil
Publish date: May 9, 2023
AGA President Dr. John Carethers described the rich history and promising future of gastroenterology in his presidential address at DDW® 2023.
News
- Author:
- Neil Osterweil
Publish date: May 8, 2023
“What we’re going to see is not just new diseases but also exacerbation of chronic diseases.”
News
- Author:
- Neil Osterweil
Publish date: May 8, 2023
Medicaid expansion may be a determinant of whether screening is even offered.
News
- Author:
- Neil Osterweil
Publish date: April 27, 2023
Study shows significant improvement in recurrence-free survival with atezolizumab and bevacizumab combo.
News
- Author:
- Neil Osterweil
Publish date: April 21, 2023
A new randomized study is the first to demonstrate improvement in recurrence-free survival in melanoma with an individualized neoantigen vaccine ap...
News
- Author:
- Neil Osterweil
Publish date: April 21, 2023
Results from a new study provide greater clarity regarding the genetic piece of the puzzle.
News
- Author:
- Neil Osterweil
Publish date: April 21, 2023
A new study’s findings confirm the benefits of neoadjuvant immunotherapy.
